| Previous Close | 3.5300 |
| Open | 3.5400 |
| Bid | 3.5200 x 1300 |
| Ask | 3.5400 x 900 |
| Day's Range | 3.5000 - 3.5600 |
| 52 Week Range | 2.5500 - 3.9500 |
| Volume | 18,265 |
| Avg. Volume | 144,500 |
| Market Cap | 99.852M |
| Beta (3Y Monthly) | 0.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.9380 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
SEATTLE, Sept. 05, 2019 -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de.